PRODUCT# 2001-P: Peroxidase-Conjugated rgp105 HIV-2
Concentration: See vial
Diluent: 50mM Tris, pH 8 1% BSA
Preservative: 0.01% Thimerasol
Stability: At least 3 months at 4°C
Minimum Dilution: 1 : 200
Application: Dot Blots, Immunohistocytology, Drug Screening, Human T-cell Research
Description: Peroxidase conjugated rgp105 HIV-2 (ROD) (Baculovirus).
Molar Ratio: 2 - 4 peroxidase molecules per molecule of gp105.
Specificity: Peroxidase conjugated rgp105 (ROD) binds to murine monoclonal antibodies of defined epitope specificity in ELISA and Western ELISA.
Biological Activity: Peroxidase conjugated rgp105 (ROD) binds to immobilized human T-cell receptor CD4 in ELISA and Western ELISA.
Application and Instructions for use
Recommended dilutions for use are approximate values. A dose dependent response assay should be performed to determine the optimal concentration for use in specific applications.
1. ELISA and Western ELISA may be performed at dilutions of 1 : 200 range depending on the concentration of CD4 in the test system. Binding to murine and human monoclonal/polyclonal antibodies may be performed at higher dilutions.
Item#: 2001 Full Length rgp105 HIV-2 (ROD)
Application: Human diagnostics, CD4 binding, Drug screening, Human T-cell CD4 studies.
Item#: 2001-G Colloidal gold-Conjugated rgp105 HIV-2 (ROD)
Application: Human diagnostics, CD4 binding, Drug screening.
Item#: 2001-F Flourescene-Conjugated rgp105 HIV-2 (ROD)
Application: FACS analysis, Histocytology.